News About Blog of the week


FREE BLOG The moral quandary of NHS Trusts going abroad

This week, we heard that a well-known UK NHS Trust is pulling out of Abu Dhabi, UAE, highlighting that exporting healthcare abroad is not for the faint-hearted. Successful or not, HBI thinks that public healthcare operators embarking on such ventures face a moral quandary.

FREE BLOG The bumpy road to cheaper insurance in Brazil

Brazilian health insurance will inevitably get cheaper - it has to. Providers are already feeling the pressure to get their act together and improve service efficiencies, but how will this happen without the entire sector moving toward DRGs?

FREE BLOG Can digital health’s new unicorns live up to their valuations?

When a start-up gets valued, it's not so much about what the company is worth today but more about how it is expected to perform over the next few years. High fundraising rounds come with big expectations from investors - will Europe's digital health companies be able to deliver?

FREE BLOG For-profit healthcare, a necessary evil in NHS systems?

In a lot of Western European countries, especially where there is a national health service funded by taxation, for-profit healthcare providers are seen at best as a necessary evil by government. Or at least, that is what they would have you believe.

FREE BLOG Finnish elderly care: under pressure and underfunded?

Finnish elderly care has been making headlines for the wrong reasons recently. Investors were left unimpressed by Attendo's Q2 results last Friday (July 19) which showed it making a loss. Its share price has almost halved since January. But it is not just Attendo feeling the heat - these are troubling times for other large operators in the Finnish elderly care market.  The CEO of Esperi Care, Finland's second wealthiest woman Marja Aarnio-Isohanni, resigned earlier this year after the country's healthcare watchdog temporarily shut down one of its facilities. Why are providers struggling in a market in desperate need of capacity?

FREE BLOG PMI and out of pocket boosts for-profit oncology in UK, Romania and India

Rates of growth vary dramatically in the for-profit oncology with mature markets with large outpatient radiotherapy sectors in France and Germany being left standing by growth rates in Emerging Markets such as India according to the latest report from HBI Intelligence. Surprisingly, the UK is also growing at 10%. 

FREE BLOG Genetic or genomic: Is bigger always better?

There are two types of testing: genetic and genomic. Genome sequencing reads each one of the three billion base pairs crammed into 23 chromosomes and their inter-relationships. Genetic testing doesn't. The two lend themselves to very different markets and produce different results. What does this mean for operators and patients?

FREE BLOG Integrated care won’t work without data

Integrating care to better meet patient needs should lead to huge improvements in outcomes. Individual patients can be targeted for prevention and their needs predicted. But this approach, which could also be labelled population health management, calls for sophisticated data sets.  The English NHS is trying to implement based on spreadsheets compiled by family doctors. It should learn from Finland and the USA. Internationally, there is a massive skills vacuum that no one is filling.

FREE BLOG Is there a market for innovation in emerging markets?

Synlab Nigeria's chief medical officer told crowds at the launch of a new wellness centre in Lagos that previously "only outdated technologies were dumped in Africa". This might be true, but is there a market for expensive innovation? 

FREE BLOG Five things we learned at HIMSS 2019

HBI attended the Healthcare Information and Management Systems Society (HIMSS) conference in Helsinki this week, alongside hundreds of health tech innovators and policymakers. Here are five things we learned.

FREE BLOG Is value health dead?

A decade ago value health was flying high. Launched by Harvard guru Michael Porter in 2006 the idea was enthusiastically espoused by Barak Obama and central to Obamacare. Then along came Trump. Meanwhile, the fiendish complexity of health care has stymied efforts. So where is it now? ICHOM 2019 in Rotterdam with 1,250 delegates was a great place to find out.

FREE BLOG Ten more things we learned at HBI 2019

Here are 10 more things that piqued our interest at HBI 2019, where sector stakeholders from payors to investors come together to grapple with the biggest and most interesting issues of the year.

FREE BLOG Can private operators beat not-for-profits on their turf?

When it comes to competition between the public sector and private operators in healthcare, the playing field is seldom even. Interestingly, however, the roles of David and Goliath in this particular matchup are often reversed depending on which country you look at, the extent to which public services are state-funded, and whether legislation is a help or a hindrance. Public and private are not, however, the only options.

FREE BLOG Things we learned at HBI 2019

This week delegates from around the world descended on London for HBI 2019 to discuss the healthcare market and its various sub-sectors. Here are the things we learnt:

FREE BLOG Where is for-profit health care heading?

The good news is it is now crystal clear what the winning business models are. The bad news is that no one has worked out how to negotiate the silos. Next week the global for-profit health care sector meets at HBI 2019 in London: What is the main theme? 

FREE BLOG Hospitals – don’t buy big for the synergies

Ramsay Generale de Sante has revealed just €20m of synergies will be gained from its Capio deal, or around 1.8% of the deal value, highlighting the lower synergies accruable in the hospital sector compared with other sectors where the synergy-to-valuation ratio can be twice as high. Ramsay Generale de Sante’s second, successful offer for the […]

FREE BLOG Digital health not yet up to global workforce challenge

The world is facing a global healthcare workforce crisis. Technology is often cited as the universal panacea to this shortfall - but digital health companies are a long way away from being able to provide a solution - even if legislation allowed them to and the public was ready to fully embrace it.

Find Us